360Dx
LightNews LightNews
banner
360dx.bsky.social
360Dx
@360dx.bsky.social
41 followers 18 following 1.3K posts
Real-time news on the IVD market from the publishers of GenomeWeb. Read the latest news at 360Dx.com.
Posts Replies Media Videos
360dx.bsky.social
www.360dx.com/regulatory-n...
Becton Dickinson, Diasorin, Visby Medical, Others Secure 510(k) Clearances in October
The US Food and Drug Administration granted clearances for PCR-based infectious disease tests from multiple companies as well as other in vitro diagnostic tests.
www.360dx.com
November 27, 2025 at 3:07 PM
360dx.bsky.social
www.360dx.com/molecular-di...
Indian Biotech Startup CrisprBits Raises $3M to Scale CRISPR Platforms for Dx, Gene Editing
The pre-Series A funding round was led by Spectrum Impact with participation from the founders and existing investors including Vijay Alreja Family Office.
www.360dx.com
November 27, 2025 at 3:07 PM
360dx.bsky.social
www.360dx.com/cancer/fda-p...
FDA Proposes Reclassification of Companion Diagnostic Tests
The agency would down-classify nucleic acid-based tests for use with a corresponding approved therapy product to Class II devices from Class III.
www.360dx.com
November 27, 2025 at 3:06 PM
360dx.bsky.social
www.360dx.com/point-care-t...
UK's Innotive Diagnostics Wins £1M Grant to Advance Development of POCT System, UTI Test
InnotiveDx's UTI diagnostic technology provides bacterial identification and antimicrobial susceptibility test results in less than 60 minutes.
www.360dx.com
November 27, 2025 at 3:06 PM
360dx.bsky.social
IHC Reference Standards Aim to Help Labs Measure Low HER2 Expression to Guide Enhertu Treatment
IHC Reference Standards Aim to Help Labs Measure Low HER2 Expression to Guide Enhertu Treatment
www.360dx.com
November 26, 2025 at 2:06 AM
Reposted by 360Dx
360dx.bsky.social
www.360dx.com/cancer/tempu...
Tempus Acquiring Pharmacogenetics Assets of Recently Defunct OneOme
The financially struggling PGx company may help Tempus expand and improve its PGx offerings.
www.360dx.com
November 25, 2025 at 12:34 AM
Reposted by 360Dx
360dx.bsky.social
www.360dx.com/cancer/abbot...
Abbott's Exact Sciences Acquisition Signals Maturation of Single-Site Specialty Dx Space
While some industry observers see the deal as a one-off, others suggested similar ones could follow as large medical firms eye fast-growing diagnostic markets.
www.360dx.com
November 24, 2025 at 10:21 PM
Reposted by 360Dx
360dx.bsky.social
Abbott Launches Into Cancer Testing Space, Doubling its Dx Total Addressable Market With Exact Sciences Buy
Abbott Launches Into Cancer Testing Space, Doubling its Dx Total Addressable Market With Exact Sciences Buy
www.360dx.com
November 24, 2025 at 10:55 PM
360dx.bsky.social
www.360dx.com/business-new...
Ovation.io, PrecisionLife Partner to Develop GLP-1 PGx Test
The test is expected to be used by payors and healthcare systems to identify people most likely to respond to the weight-loss drugs.
www.360dx.com
November 25, 2025 at 5:49 PM
360dx.bsky.social
www.360dx.com/molecular-di...
Indian Biotech Startup CrisprBits Raises $3M to Scale CRISPR Platforms for Dx, Gene Editing
The pre-Series A funding round was led by Spectrum Impact with participation from the founders and existing investors including Vijay Alreja Family Office.
www.360dx.com
November 25, 2025 at 5:48 PM
360dx.bsky.social
www.360dx.com/business-new...
Agilent Technologies Fiscal Q4 Revenues Rise 9 Percent on Strength in Life Sciences, Diagnostics
The company beat analysts' average estimates on the top and bottom lines and guided to $7.3 billion to $7.4 billion in revenues for fiscal 2026.
www.360dx.com
November 25, 2025 at 3:52 PM
360dx.bsky.social
www.360dx.com/business-new...
Thermo Fisher Scientific Prices €2.1B Senior Notes Offering
The firm intends to use the proceeds for general corporate purposes, which may include the acquisition of companies or businesses and the repayment of debt.
www.360dx.com
November 25, 2025 at 3:51 PM
360dx.bsky.social
www.360dx.com/cancer/tempu...
Tempus Acquiring Pharmacogenetics Assets of Recently Defunct OneOme
The financially struggling PGx company may help Tempus expand and improve its PGx offerings.
www.360dx.com
November 25, 2025 at 12:34 AM
360dx.bsky.social
Abbott Launches Into Cancer Testing Space, Doubling its Dx Total Addressable Market With Exact Sciences Buy
Abbott Launches Into Cancer Testing Space, Doubling its Dx Total Addressable Market With Exact Sciences Buy
www.360dx.com
November 24, 2025 at 10:55 PM
360dx.bsky.social
www.360dx.com/cancer/abbot...
Abbott Launches Into Cancer Testing Space, Doubling its Dx Total Addressable Market With Exact Sciences Buy
According to some experts, the deal could be the start of additional sizable M&A activity in the diagnostics space.
www.360dx.com
November 24, 2025 at 10:21 PM
360dx.bsky.social
www.360dx.com/cancer/abbot...
Abbott's Exact Sciences Acquisition Signals Maturation of Single-Site Specialty Dx Space
While some industry observers see the deal as a one-off, others suggested similar ones could follow as large medical firms eye fast-growing diagnostic markets.
www.360dx.com
November 24, 2025 at 10:21 PM
360dx.bsky.social
www.360dx.com/regulatory-n...
Diasorin Submits Liaison Plex Molecular GI Panel for FDA 510(k) Clearance
The syndromic testing panel runs on the company's Liaison PCR-based molecular diagnostics system and detects 24 gastrointestinal pathogen targets.
www.360dx.com
November 24, 2025 at 10:20 PM
360dx.bsky.social
www.360dx.com/molecular-di...
Oasis Diagnostics, Oludent Health International Strike Saliva-Based Dx Alliance
The companies will work together to offer saliva-based diagnostic products in Africa, the Middle East, and Southeast Asia.
www.360dx.com
November 24, 2025 at 10:20 PM
360dx.bsky.social
www.360dx.com/cardiovascul...
CAP Publishes Guidelines for Standardized Amyloidosis Diagnosis, Subtyping
The CAP committee recommended that pathologists use mass spectrometry to determine the subtype for amyloidosis patients being considered for treatment.
www.360dx.com
November 24, 2025 at 10:19 PM
360dx.bsky.social
www.360dx.com/regulatory-n...
C2N Diagnostics Receives Lab Permit From NY State
With the permit, St. Louis-based C2N can offer its PrecivityAD2 and PrecivityAD Alzheimer's blood tests to patients in New York state.
www.360dx.com
November 24, 2025 at 3:12 PM
360dx.bsky.social
www.360dx.com/molecular-di...
Following Pilot Trial Success, Ocean Diagnostics Aims for 2028 Rapid Sepsis ID Launch
The five-hour test recently demonstrated 100 percent concordance with the standard-of-care assay as well as a high negative predictive value.
www.360dx.com
November 24, 2025 at 2:57 PM
360dx.bsky.social
www.360dx.com/business-new...
Top Five Articles on 360Dx Last Week: Abbott Buying Exact Sciences; Changes at Siemens Healthineers; More
Last week, readers were most interested in a story about a proposed acquisition by Abbott of Exact Sciences that would launch Abbott into the cancer testing space.
www.360dx.com
November 24, 2025 at 2:56 PM
360dx.bsky.social
www.360dx.com/business-new...
In New Company Configuration, Siemens Healthineers to Launch 30 Tests, Consolidate Portfolio
The firm's new strategy revolves around adding to its test menu in an impactful way and expanding its installed base of instruments.
www.360dx.com
November 21, 2025 at 3:06 PM
360dx.bsky.social
www.360dx.com/business-new...
In Brief This Week: Agilent Technologies, Nanopath, LuminoDx, Mainz Biomed, Burning Rock Biotech, More
News items for the week of Nov. 17, 2025
www.360dx.com
November 21, 2025 at 3:06 PM
360dx.bsky.social
www.360dx.com/neurological...
French Dx Firm Alcediag Aims to Expand Reach of Test for Depression, Bipolar Disorder
The test is intended for patients with moderate to severe depression and differentiates between unipolar and bipolar depression.
www.360dx.com
November 20, 2025 at 10:05 PM